Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTNM Contineum Therapeutics, INC.

交易中 06-03 09:48:44 EDT

12.50

+0.12

+0.97%

最高12.54	最低12.20	成交量2.42万
今开12.43	昨收12.38	日振幅2.71%
总市值4.67亿	流通市值2.76亿	总股本3,734万
成交额29.96万	换手率0.11%	流通股本2,209万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":12.5,"timestamp":1780494521118,"preClose":12.38,"halted":0,"volume":24202,"delay":0,"changeRate":0.00969305331179315,"floatShares":22092600,"shares":37336000,"eps":-1.91379,"marketStatus":"交易中","change":0.12,"latestTime":"06-03 09:48:44 EDT","open":12.43,"high":12.535,"low":12.2,"amount":299604.121125,"amplitude":0.02706,"askPrice":12.54,"askSize":100,"bidPrice":12.22,"bidSize":106,"shortable":3,"etf":0,"ttmEps":-1.91379,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1780516800000},"marketStatusCode":2,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":12.38,"preHourTrading":{"tag":"盘前","latestPrice":12.43,"preClose":12.38,"latestTime":"09:26 EDT","volume":1,"amount":12.43,"timestamp":1780493164703,"change":0.05,"changeRate":0.004039,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.38,"preClose":12.38,"latestTime":"18:52 EDT","volume":244,"amount":3021.74,"timestamp":1780440728621,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.479997,"impliedVol":0.6873,"impliedVolPercentile":0.2231},"requestUrl":"/m/hq/s/CTNM","defaultTab":"news","newsList":[{"id":"1104567260","title":"Contineum Therapeutics公司Pipe-791药物1B期临床试验达到安全性与耐受性主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1104567260","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104567260?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:07","pubTimestamp":1777579626,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics公司宣布，其研发的Pipe-791在1B期临床试验中成功达到安全性及耐受性的主要研究终点。这一重要进展为后续临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146134593","title":"Contineum Therapeutics公布慢性疼痛探索性Pipe-791 1B期试验积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1146134593","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146134593?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:06","pubTimestamp":1777579590,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics宣布其针对慢性疼痛的探索性Pipe-791 1B期临床试验获得积极顶线结果。这项关键研究标志着该公司在疼痛管理领域的重要进展。试验数据为后续临床开发提供了有力支持，展现出该疗法在慢性疼痛治疗中的潜在价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160802484","title":"Contineum Therapeutics公司拟通过Leerink Partners发行A类普通股 募资额最高达1亿美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1160802484","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160802484?lang=zh_cn&edition=full","pubTime":"2026-03-06 05:51","pubTimestamp":1772747498,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新公开的文件显示，生物制药企业Contineum Therapeutics Inc.已启动一项新股发行计划。该公司拟通过承销商Leerink Partners，向市场公开发行其A类普通股，此次募资规模最高可达1亿美元。\n此次融资计划旨在为公司的临床阶段研发项目提供资金支持，进一步推进其神经系统疾病治疗药物的开发进程。具体发行条款，包括发行价格、股票数量及最终募资规模，将根据市场情况最终确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119669221","title":"Contineum Therapeutics公布2025年第四季度财务业绩，重申关键临床开发里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1119669221","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119669221?lang=zh_cn&edition=full","pubTime":"2026-03-06 05:07","pubTimestamp":1772744832,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics（股票代码：CTNM）已正式披露其2025年第四季度的财务报告。公司同时确认，其核心临床开发项目正按计划推进，关键里程碑节点保持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140088540","title":"Contineum Therapeutics Inc - Pipe-791第二阶段试验预计将于2028年6月完成 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1140088540","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140088540?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:46","pubTimestamp":1765489577,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Inc - Pipe-791第二阶段试验预计将于2028年6月完成 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518209152","title":"Contineum Therapeutics, Inc.盘中异动 大幅上涨5.61%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209152?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:12","pubTimestamp":1741623143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时12分，Contineum Therapeutics, Inc.股票出现波动，股价急速拉升5.61%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3682.97%、3096.68%、934.35%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001223abf33647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001223abf33647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518028494","title":"Contineum Therapeutics, Inc.2024财年实现净利润-42.26百万美元，同比减少286.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518028494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518028494?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536082,"startTime":"0","endTime":"0","summary":"3月10日，Contineum Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-42.26百万美元，同比减少286.00%；其中营业收入为0.00美元，每股基本收益为-1.63美元。从资产负债表来看，Contineum Therapeutics, Inc.总负债14.78百万美元，其中短期债务1.45百万美元，资产负债比为0.15，流动比率为0.21。机构评级：截至2025年3月10日，当前有4家机构对Contineum Therapeutics, Inc.目标价做出预测，其中目标均价为25.25美元，其中最低目标价为16.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000309a268989a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000309a268989a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517311453","title":"Contineum Therapeutics(CTNM.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.56美元，前值为-3.32美元，预期值为-0.44美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517311453","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517311453?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301842,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics(CTNM.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.56美元，前值为-3.32美元，预期值为-0.44美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110836424","title":"Contineum Therapeutics 2024年第四季度GAAP每股收益$(0.56)错过$(0.46)预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1110836424","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110836424?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:18","pubTimestamp":1741295923,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics（纳斯达克代码：CTNM）报告季度每股亏损$(0.56)，比分析师普遍预期的$(0.46)低21.74％。以上内容来自Benzinga Earnings专栏，原文如下：Contineum $Therapeutics(LENZ)$ (NASDAQ:CTNM) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.46) by 21.74 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517816182","title":"Contineum Therapeutics, Inc.盘中异动 股价大涨5.74%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517816182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517816182?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:08","pubTimestamp":1741273709,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时08分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨5.74%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230829989ebc42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230829989ebc42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTNM","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517864559","title":"Contineum Therapeutics, Inc.盘中异动 临近收盘股价大跌5.16%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517864559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517864559?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:01","pubTimestamp":1741122119,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日05时01分，Contineum Therapeutics, Inc.股票出现异动，股价大幅下跌5.16%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050159abe85d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050159abe85d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634971","title":"Contineum Therapeutics, Inc.盘中异动 早盘股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634971?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:38","pubTimestamp":1741012717,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时38分，Contineum Therapeutics, Inc.股票出现异动，股价快速上涨5.82%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.65%、42.33%、31.64%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为27.23%、19.25%、18.04%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238389637ae33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238389637ae33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513216482","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.44%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513216482?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:31","pubTimestamp":1740162660,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时31分，Contineum Therapeutics, Inc.股票出现波动，股价大幅跳水5.44%。截至发稿，该股报7.47美元/股，成交量3.4271万股，换手率0.13%，振幅7.66%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023100988e128b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023100988e128b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTNM","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512622191","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512622191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512622191?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:21","pubTimestamp":1739910099,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时21分，Contineum Therapeutics, Inc.股票出现波动，股价快速下挫5.05%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为899.47%、214.60%、172.60%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042140988a3433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042140988a3433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTNM","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511961226","title":"Contineum Therapeutics, Inc.盘中异动 早盘急速上涨5.57%报8.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511961226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511961226?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:40","pubTimestamp":1739544055,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时40分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨5.57%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224055a2460349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224055a2460349&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508142837","title":"Contineum Therapeutics, Inc.盘中异动 早盘急速下跌5.26%报9.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142837?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:04","pubTimestamp":1738595089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时04分，Contineum Therapeutics, Inc.股票出现异动，股价快速跳水5.26%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为482.54%、390.34%、255.71%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.62%、64.33%、50.76%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230449961701a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230449961701a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505093452","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505093452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505093452?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:01","pubTimestamp":1737478877,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时01分，Contineum Therapeutics, Inc.股票出现波动，股价快速跳水5.08%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为765.77%、497.64%、184.88%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010118abb36707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010118abb36707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504949496","title":"Contineum Therapeutics, Inc.盘中异动 大幅下挫5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504949496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504949496?lang=zh_cn&edition=full","pubTime":"2025-01-17 03:01","pubTimestamp":1737054077,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日03时01分，Contineum Therapeutics, Inc.股票出现异动，股价大幅下挫5.94%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170301179868c19e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170301179868c19e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503647090","title":"Contineum Therapeutics, Inc.盘中异动 快速拉升6.23%报13.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647090?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951630,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨6.23%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Allovir, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.65%、57.74%、35.58%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223350ababf31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223350ababf31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTNM","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contineum-tx.com","stockEarnings":[{"period":"1week","weight":-0.0964},{"period":"1month","weight":-0.0621},{"period":"3month","weight":-0.1669},{"period":"6month","weight":0.1275},{"period":"1year","weight":1.7946},{"period":"ytd","weight":0.0831}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.054},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.1098},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Contineum Therapeutics, Inc.于2009年在特拉华州注册成立，最初名为Versense Pharmaceuticals, Inc.，后经多次合并与更名，于2023年11月采用现名。该公司是一家临床阶段的生物制药企业，专注于为具有重大未满足需求的神经炎症和免疫学适应症开发差异化的口服小分子疗法。其产品线包括全资拥有的用于特发性肺纤维化和慢性疼痛的候选药物PIPE-791，以及合作开发的用于抑郁症和多发性硬化症的候选药物PIPE-307。","exchange":"NASDAQ","name":"Contineum Therapeutics, INC.","nameEN":"Contineum Therapeutics, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Contineum Therapeutics, INC.(CTNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Contineum Therapeutics, INC.,CTNM,Contineum Therapeutics, INC.股票,Contineum Therapeutics, INC.股票老虎,Contineum Therapeutics, INC.股票老虎国际,Contineum Therapeutics, INC.行情,Contineum Therapeutics, INC.股票行情,Contineum Therapeutics, INC.股价,Contineum Therapeutics, INC.股市,Contineum Therapeutics, INC.股票价格,Contineum Therapeutics, INC.股票交易,Contineum Therapeutics, INC.股票购买,Contineum Therapeutics, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Contineum Therapeutics, INC.(CTNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}